Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy
Open Access Macedonian Journal of Medical Sciences2019Vol. 7(23), pp. 3921–3924
Citations Over TimeTop 14% of 2019 papers
Abstract
Inhibition of receptor for advanced glycation end-products (RAGE) was effective in suppressing the development and progression of diabetic retinopathy.
Related Papers
- → The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs(2014)182 cited
- → Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk(2014)68 cited
- [AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers].(2014)
- → ADVANCED GLYCATION END PRODUCTS AND THEIR RECEPTORS IN CARDIOVASCULAR DISEASES(2019)4 cited
- The pathogenesis of receptor for advanced glycation end products in diabetic chronic complication(1999)